Items Tagged ‘Clifford Jack Jr.’
August 26, 2020
Mayo Clinic Research in the news — 8/26/2020
Although it hasn’t even been a week, many news outlets have featured Mayo Clinic Research and our research experts in articles across a broad range of topics. In order not to overload – it really is shaping up to be an interesting week – we’ll save COVID-related news for another day. Read on to hear […]
Tags: Allisa Song, Alzheimer's disease, animal model, Clifford Jack Jr., dogs, fibromyalgia, hypertension, liver disease, Mayo Clinic Alix School of Medicine, Mayo Clinic Proceedings, medical research education, menopause
August 14, 2020
Mayo Clinic Research in the news 8/14/2020
While much of the news around health care research is COVID-19 related, Mayo Clinic researchers are hard at work across the entire spectrum of health and health care delivery. Our multidisciplinary research teams are seeking ways to improve outcomes, lower costs and enhance the experience of patients, providers and caregivers. Read on for snippets of […]
Tags: aging, Andrew Badley, antibodies, breast cancer, chemotherapy, Clifford Jack Jr., clinical research, clinical trials, COVID-19, Devon Rubin, Eugenia Trushina, Grzegorz Nowakowski
November 13, 2019
By Advancing the Science contributor 
By Mass General Research Communications Staff Stroke is the leading cause of adult disability in the US, with up to 70% of stroke survivors suffering some degree of post-stroke VCID. Furthermore, some stroke subtypes carry a disproportionate burden of the disability related to stroke. We are excited to announce that, last month, the National Institute […]
Tags: aging, Clifford Jack Jr., cognitive impairment, collaboration, David Knopman, dementia, James Meschia, Jonathan Graff-Radford, Kevin Barrett, Mayo Clinic Study of Aging, neurology, Prashanthi Vemuri
July 10, 2019
Biomarkers could help early diagnosis of Alzheimer’s
By Advancing the Science contributor
Early diagnosis will ultimately be essential in the management and treatment of Alzheimer’s disease. Examination of Alzheimer’s biomarkers can improve the prediction of short-term memory decline in middle-age and elderly individuals, according to new research led by Mayo Clinic.
Tags: Alzheimer's disease, biomarkers, Clifford Jack Jr., Mayo Clinic Study of Aging, Rochester Epidemiology Project